FDA Drug Application (022185) for TACLONEX by LEO PHARMA AS

Back to FDA Applications sponsored by LEO PHARMA AS

Application Number022185
Product Number001
FormSUSPENSION;TOPICAL
Dosage0.064%;0.005%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTACLONEX
Active IngredientBETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE



Back to FDA Applications sponsored by LEO PHARMA AS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.